Correlation Engine 2.0
Clear Search sequence regions

  • antitumor (1)
  • ATP (3)
  • dmso (1)
  • doxorubicin (1)
  • female (1)
  • humans (1)
  • mice (2)
  • mice balb c (1)
  • mice nude (1)
  • P gp (3)
  • paclitaxel (2)
  • taxol (1)
  • time factors (1)
  • verapamil (1)
  • vitamin e (4)
  • xenograft (2)
  • Sizes of these terms reflect their relevance to your search.

    Multidrug resistance (MDR) is a major obstacle to successful and effective chemotherapeutic treatments of cancers. This study explored the reversal effects of vitamin E on MDR tumor cells in vitro and in vivo, elucidating the potential mechanism of this reversal. VE at a concentration of 50 μM exhibited a significant reversal of the MDR effect (compared to only PTX in DMSO, p<0.05) in two human MDR cell lines (H460/taxR and KB-8-5). The MDR cell xenograft model was established to investigate the effect of VE on reversing MDR in vivo. Mice intravenously injected with Taxol (10 mg/kg) with VE (500 mg/kg, IP) showed an ability to overcome the MDR. VE and its derivatives can significantly increase intracellular accumulation of rhodamine 123 and doxorubicin (P-gp substrate), but not alter the levels of P-gp expression. These treatments also did not decrease the levels of intracellular ATP, but were still able to inhibit the verapamil-induced ATPase activity of P-gp. The new application of VE as an MDR sensitizer will be attractive due to the safety of this treatment. Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.


    Jingling Tang, Qiang Fu, Yongjun Wang, Kelly Racette, Dun Wang, Feng Liu. Vitamin E reverses multidrug resistance in vitro and in vivo. Cancer letters. 2013 Aug 09;336(1):149-57

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 23624302

    View Full Text